ArticleCancer medicine2025
Segment Anything Model for Gastric Cancer.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Rethinking pathology image analysis through shuffling.npj biomedical innovations · 2026Article
- [CGP-Net: Cross-modal guided prior network for precise gastric cancer segmentation].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
- Segment Anything Model for Gastric Cancer.Cancer medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundGastric cancer is a biologically aggressive disease, accounting for a substantial proportion of cancer-related deaths globally. Accurate localization of the lesion by artificial intelligence techniques helps timely and efficiently diagnose and treat. Segment Anything Model (SAM) has demonstrated considerable potential in medical image segmentation by displaying high performance in numerous image benchmark tests. However, its resource-intensive nature limits feasibility in embedded medical contexts.
methodsThis study proposed GC-SAM, a lightweight model for tumor segmentation. The architecture of GC-SAM is innovatively proposed, including a knowledge distillation image encoder, prompt encoder, and mask decoder, which effectively replaces the conventional fixed and computationally intensive network components.
resultsExtensive experiments demonstrate that GC-SAM significantly outperforms both classical segmentation models and recent state-of-the-art networks. On the internal test set, GC-SAM achieves 0.8186 Dice and 0.6504 mIoU, while reducing inference time and parameter count by over 80% compared to the original SAM. On the external dataset, GC-SAM maintains superior performance (Dice 0.8350), demonstrating excellent generalization.
conclusionsThe proposed GC-SAM model shows strong capability in segmenting gastric cancer tissue, while also demonstrating practical potential for deployment in embedded medical imaging devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.